133 related articles for article (PubMed ID: 28842140)
21. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
22. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
Parikh SA; Tefferi A
Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
[TBL] [Abstract][Full Text] [Related]
23. Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome.
Patnaik MM; Wassie EA; Lasho TL; Hanson CA; Ketterling R; Tefferi A
Am J Hematol; 2015 May; 90(5):411-6. PubMed ID: 25645147
[TBL] [Abstract][Full Text] [Related]
24. Chronic myelomonocytic leukemia.
Bennett JM
Curr Treat Options Oncol; 2002 Jun; 3(3):221-3. PubMed ID: 12057067
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
[TBL] [Abstract][Full Text] [Related]
26. Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.
Wassie EA; Itzykson R; Lasho TL; Kosmider O; Finke CM; Hanson CA; Ketterling RP; Solary E; Tefferi A; Patnaik MM
Am J Hematol; 2014 Dec; 89(12):1111-5. PubMed ID: 25195656
[TBL] [Abstract][Full Text] [Related]
27. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
[TBL] [Abstract][Full Text] [Related]
28. Immune thrombocytopenia in chronic myelomonocytic leukemia.
Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
[TBL] [Abstract][Full Text] [Related]
29. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant.
Yamamoto M; Nakagawa M; Ichimura N; Ohtsuki F; Ohtsuka Y; Tsujino Y; Tanaka A; Kamiya T; Wada H
Am J Hematol; 1996 Jul; 52(3):212-4. PubMed ID: 8756090
[TBL] [Abstract][Full Text] [Related]
30. [Juvenile chronic leukemia and chronic myelomonocytic leukemia. Experiences with bone marrow transplantation in childhood in 5 cases].
Pechumer H; Bender-Götze C; Walther JU; Klingebiel T; Ehninger G; Suttorp M; Schmitz N
Monatsschr Kinderheilkd; 1992 May; 140(5):307-12. PubMed ID: 1614461
[TBL] [Abstract][Full Text] [Related]
31. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
32. Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience.
Subari S; Patnaik M; Alfakara D; Gangat N; Elliott M; Hogan W; Litzow M; Al-Kali A
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):546-9. PubMed ID: 26189785
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
Wijermans PW; Rüter B; Baer MR; Slack JL; Saba HI; Lübbert M
Leuk Res; 2008 Apr; 32(4):587-91. PubMed ID: 17881052
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Onida F; Kantarjian HM; Smith TL; Ball G; Keating MJ; Estey EH; Glassman AB; Albitar M; Kwari MI; Beran M
Blood; 2002 Feb; 99(3):840-9. PubMed ID: 11806985
[TBL] [Abstract][Full Text] [Related]
35. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
[TBL] [Abstract][Full Text] [Related]
36. Effect of chemotherapy for the dysmyelopoietic syndrome.
Armitage JO; Dick FR; Needleman SW; Burns CP
Cancer Treat Rep; 1981; 65(7-8):601-5. PubMed ID: 6941853
[TBL] [Abstract][Full Text] [Related]
37. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center.
González-Medina I; Bueno J; Torrequebrada A; López A; Vallespí T; Massagué I
Leuk Res; 2002 Sep; 26(9):821-4. PubMed ID: 12127557
[TBL] [Abstract][Full Text] [Related]
38. Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
Harel S; Cherait A; Berthon C; Willekens C; Park S; Rigal M; Brechignac S; Thépot S; Quesnel B; Gardin C; Adès L; Fenaux P; Braun T
Leuk Res; 2015 May; 39(5):501-4. PubMed ID: 25735917
[TBL] [Abstract][Full Text] [Related]
39. Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia.
Etzell J; Lu CM; Browne LW; Wang E
Am J Hematol; 2005 Aug; 79(4):340-2. PubMed ID: 16044446
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
Ngo NT; Lampert IA; Naresh KN
Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]